Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Plasma microRNAs as potential biomarkers in early Alzheimer disease expression
Carmen Peña‐Bautista, Adrián Tarazona-Sánchez, Aitana Braza‐Boïls, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Potential Implications of miRNAs in the Pathogenesis, Diagnosis, and Therapeutics of Alzheimer’s Disease
Long Wang, Xindong Shui, Yuelin Diao, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16259-16259
Open Access | Times Cited: 19
Non-invasive Biomarkers for Early Detection of Alzheimer’s Disease: a New-Age Perspective
Niyamat M. A. Chimthanawala, Akash Haria, Sadhana Sathaye
Molecular Neurobiology (2023) Vol. 61, Iss. 1, pp. 212-223
Closed Access | Times Cited: 17
Profiling Small RNA From Brain Extracellular Vesicles in Individuals With Depression
Pascal Ibrahim, Ryan Denniston, Haruka Mitsuhashi, et al.
The International Journal of Neuropsychopharmacology (2024) Vol. 27, Iss. 3
Open Access | Times Cited: 7
Epigenetics of Ageing and Psychiatric Disorders
Cezar-Ivan Coliță, Ion Udriștoiu, Diana–Larisa Ancuta, et al.
Journal of Integrative Neuroscience (2024) Vol. 23, Iss. 1, pp. 13-13
Open Access | Times Cited: 6
Decreased miR-451a in cerebrospinal fluid, a marker for both cognitive impairment and depressive symptoms in Alzheimer's disease
Feng Hu, Panpan Hu, Yan Chen, et al.
Theranostics (2023) Vol. 13, Iss. 9, pp. 3021-3040
Open Access | Times Cited: 13
MicroRNA in neuroexosome as a potential biomarker for HIV-associated neurocognitive disorders
Kotaro Arizono, Ayako Sedohara, Khulan Tuvshinjargal, et al.
Journal of NeuroVirology (2025)
Open Access
MicroRNA Expression in Asymptomatic Welders: Implications for Biomarker Discovery for Environmentally-Linked Neurodegenerative Disorders
Alejandra Bargues-Carot, Janina Manzieri Prado‐Rico, Yuka Imamura Kawasawa, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Electrochemical biosensors for early detection of Alzheimer’s disease
Sanoeva Matlyuba Jakhonkulovna, Gulnoz Bahodirova Kamolovna, Muzaffar Zokirov, et al.
Clinica Chimica Acta (2025), pp. 120278-120278
Closed Access
Cerebrospinal fluid microRNAs as potential biomarkers in Alzheimer’s disease
Ahmed Noor Eddin, Khaled Hamsho, Ghaith Adi, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 12
A review on the new age methodologies for early detection of Alzheimer's and Parkinson's disease
Nabanita Ghosh, Krishnendu Sinha, Parames C. Sil
Basic & Clinical Pharmacology & Toxicology (2024) Vol. 134, Iss. 5, pp. 602-613
Open Access | Times Cited: 4
Sarcopenia as a Risk Factor for Alzheimer’s Disease: Genetic and Epigenetic Perspectives
Stuart M. Raleigh, Kayleigh J. A. Orchard
Genes (2024) Vol. 15, Iss. 5, pp. 561-561
Open Access | Times Cited: 4
Blood-Based Biomarkers in Alzheimer’s Disease: Advancing Non-Invasive Diagnostics and Prognostics
Mrinmay Dhauria, Ritwick Mondal, Shramana Deb, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 10911-10911
Open Access | Times Cited: 4
Molecular Mechanisms of Dietary Bioactive Peptides in Treating Alzheimer’s Disease and Mild Cognitive Impairment by Network Pharmacology and Molecular Docking Analysis
Ruirui Li, Jing Zi, Y. Hu, et al.
Rejuvenation Research (2025)
Closed Access
Advanced Biomarkers: Beyond Amyloid and Tau: Emerging Non-Traditional Biomarkers for Alzheimer’s Diagnosis and Progression
Meher Rijwana Afrin, P. Upadhyaya, A. Hashim, et al.
Ageing Research Reviews (2025), pp. 102736-102736
Closed Access
New approach for early and specific Alzheimer disease diagnosis from different plasma biomarkers
Anabel Forte, Sergio Antonio Oropeza-de Lara, Carmen Peña‐Bautista, et al.
Clinica Chimica Acta (2024) Vol. 556, pp. 117842-117842
Closed Access | Times Cited: 3
Insights into role of microRNA in Alzheimer's disease: From contemporary research to bedside perspective
Mounisha Bandakinda, Awanish Mishra
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 126561-126561
Closed Access | Times Cited: 8
Alzheimer's disease‐induced phagocytic microglia express a specific profile of coding and non‐coding RNAs
Flavia Scoyni, Luca Giudice, Mari‐Anna Väänänen, et al.
Alzheimer s & Dementia (2023) Vol. 20, Iss. 2, pp. 954-974
Open Access | Times Cited: 8
Understanding the multifaceted role of miRNAs in Alzheimer’s disease pathology
Sharanjot Kaur, Harkomal Verma, Sukhchain Kaur, et al.
Metabolic Brain Disease (2023) Vol. 39, Iss. 1, pp. 217-237
Closed Access | Times Cited: 7
Exploring the Regulatory Landscape of Dementia: Insights from Non-Coding RNAs
Jung-min Kim, Woo Ryung Kim, Eun Gyung Park, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6190-6190
Open Access | Times Cited: 2
The role of exosome-shuttled miRNAs in heavy metal-induced peripheral tissues and neuroinflammation in Alzheimer's disease
Qing Dong, Huanyong Fu, Hong Jiang
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116880-116880
Open Access | Times Cited: 2
Systems Medicine as a Strategy to Deal with Alzheimer’s Disease
Xiao Xue Zeng, Jie Zeng
Journal of Alzheimer s Disease (2023) Vol. 96, Iss. 4, pp. 1411-1426
Closed Access | Times Cited: 4
Changes in cognitive ability and serum microRNA levels during aging in mice
Keisuke Yamamoto, K. Miyano, M. Fujita, et al.
Experimental and Therapeutic Medicine (2024) Vol. 27, Iss. 3
Open Access | Times Cited: 1
Identification of Autophagy-Related Biomarkers and Diagnostic Model in Alzheimer’s Disease
Wei Xu, Xi Su, Jing Qin, et al.
Genes (2024) Vol. 15, Iss. 8, pp. 1027-1027
Open Access | Times Cited: 1
Current progress in microRNA profiling of circulating extracellular vesicles in amyotrophic lateral sclerosis: A systematic review
Yuji Ueno, Yuto Morishima, Takanori Hata, et al.
Neurobiology of Disease (2024) Vol. 200, pp. 106639-106639
Open Access | Times Cited: 1
The study of Alzheimer's disease risk diagnosis based on natural killer cell marker genes in the multi-omics data
Xiaorong Chen, Fenggen Hu, Qingjia Chi, et al.
Journal of Alzheimer s Disease (2024)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top